Searchable abstracts of presentations at key conferences in endocrinology

ea0081p79 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Non-invasive quantification of pancreatic islet beta-cell function in people with type 1 diabetes mellitus

Joshi Shruti , Singh Trisha , Kershaw Lucy , Gibb Fraser , Dweck Marc R , Williams Michelle , Semple Scott , Forbes Shareen , Reynolds Rebecca , Newby David

Background and Aims: Type 1 diabetes mellitus (T1DM) is characterised by autoimmune destruction of pancreatic beta-cells resulting in insulin deficiency. Evaluation of novel therapies for T1DM requires reliable methods to measure beta-cell function, which is unattainable using traditional non-invasive imaging techniques. A new approach is manganese-enhanced magnetic resonance imaging (MEMRI). As a calcium analogue, manganese is taken up into pancreatic beta-cells during insuli...

ea0094oc5.6 | Adrenal and Cardiovascular | SFEBES2023

11βHSD1 inhibition improves cardiac function compared to standard therapy in a translational pig mode through regulation of extracellular matrix

Al Disi Sara , Ascione Raimondo , Johnson Tom , Sammut Eva , Domenico Bruno Vito , Khan Shazia , Singh Trisha , Baz Lopez Daniel , James Carol-Ann , Walker Brian , Mills Nicholas , Webster Scott , Freeman Adrian , Whittaker Andrew , Andrew Ruth , Gray Gillian

Glucocorticoids (GCs) protect cardiomyocytes immediately after myocardial infarction (MI), but GCs subsequently regenerated within the heart by 11β-hydroxysteroid dehydrogenase 1 (11βHSD1) are detrimental during infarct repair, with functional outcomes post-MI improved in mice lacking 11βHSD1. Pharmacological 11βHSD1 inhibition (AZD8329 50mg/kg, 11βHSD1i) was compared to standard clinical therapy (SCT) in a translational pig model (female, 11βHSD1...